CLINICAL TRIALS PROFILE FOR LOMAIRA
✉ Email this page to a colleague
All Clinical Trials for LOMAIRA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03374956 ↗ | Individualized Obesity Pharmacotherapy | Active, not recruiting | Mayo Clinic | Phase 3 | 2017-12-11 | The researchers are trying to identify the specific characteristics (phenotypes) that may be useful to help select the right medication for weight loss. |
NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | University of Colorado- Clinical and Translational Sciences Institute | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | University of Colorado- Nutrition Obesity Research Center | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
NCT04095104 ↗ | Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds | Recruiting | Jaime Moore, MD MPH | Phase 2 | 2020-01-15 | The goal of this pilot study is to establish the feasibility and initial efficacy of the combination of phentermine and topiramate for adolescents and young adults who require additional risk reduction after bariatric surgery. This study will use a randomized, placebo-controlled, double-blinded design to evaluate an adjunctive 12-week intervention of phentermine + topiramate + standard of care vs. placebos + standard of care 6 months after bariatric surgery, among 12 to 24 year olds who don't achieve expected weight loss or who remain severely obese (n=10 total). |
NCT04614545 ↗ | Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity | Active, not recruiting | The Cleveland Clinic | Phase 4 | 2021-01-01 | This study will study the effects associated with the prescription of phentermine in a virtual setting, comparing with prescription of phentermine via a standard face-to-face visit for patients with obesity or overweight. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LOMAIRA
Condition Name
Clinical Trial Locations for LOMAIRA
Trials by Country
Clinical Trial Progress for LOMAIRA
Clinical Trial Phase
Clinical Trial Sponsors for LOMAIRA
Sponsor Name